Search clinical trials for: Mithramycin

Total 3 results

National Cancer Institute (NCI)

Terminated

Mithramycin for Lung, Esophagus, and Other Chest Cancers

Gastrointestinal Neoplasms | Breast Cancer | Esophageal Cancer | Lung Cancer | Mesothelioma

United States
National Cancer Institute (NCI)

Terminated

Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma

Sarcoma | Ewing Sarcoma

United States
National Cancer Institute (NCI)

Terminated

Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases

Neoplasms, Germ Cell and Embryonal | Lung Neoplasms | Esophageal Neoplasms | Thymus Neoplasms | Mesothelioma

United States

3

Subscribe